Report cover image

Global GLP-1 Analogues Market

Publisher BCC Research
Published Dec 04, 2025
Length 85 Pages
SKU # WA20658066

Description

Report Scope

This report provides detailed information on glucagon-like peptide-1 (GLP-1) analogues. It analyzes market trends for GLP-1 analogues, with data from 2024, estimates from 2025, projections of compound annual growth rates (CAGRs) through 2030 (the forecast period 2025–2030) and regional markets for GLP-1 analogues. This report highlights the current and future market potential of GLP-1 analogues and provides a detailed analysis of the competitive environment. It covers regulatory scenarios, drivers, restraints and opportunities, along with the market projections for 2030 and market share for key companies.

The GLP-1 analogue market is segmented by route of administration into oral and injection. By region, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China and India. For market estimates, 2024 is used as the base year, with forecasts for 2025 and a projected value for 2030.

The report aims to:
  • Analyze the market for GLP-1 analogues.
  • Analyze the global market size and market segments.
  • Understand market constraints and drivers.
  • Provide detailed market forecasts for 2030.
  • Assess market share, competitiveness and industry structure.
  • Identify potential long-term impacts on the GLP-1 analogue market.
Report Includes
  • An overview of the current and future global markets for GLP-1 analogues
  • In-depth analysis of global market trends, featuring historical revenue data for 2022–2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
  • Estimates of the size and revenue prospects of the global market, along with a market share analysis by route of administration, indication and region
  • Facts and figures pertaining to the market dynamics, technical advances, regulations and the impact of macroeconomic factors
  • An analysis of patents, emerging trends and developments in the industry
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Profiles of the leading companies


Companies Mentioned

Hansoh Pharmaceutical Group Co. Ltd.
Lilly Usa Llc.
Novo Nordisk A/S
Sanofi
Shanghai Benemae Pharmaceutical Corp.
Teva Pharmaceutical Industries Ltd.

Table of Contents

85 Pages
Chapter 1 Executive Summary
Market Outlook
Scope Of Report
Market Summary
Market Dynamics And Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Analysis Of Macroeconomic Factors
Impact Of U.S. Tariffs On The Pharmaceutical Industry
Healthcare Expenditure
Market Demand And Demographics
Porter's Five Forces Analysis
Bargaining Power Of Buyers (High)
Bargaining Power Of Suppliers (Moderate To High)
Potential For New Entrants (Low)
Threat Of Substitutes (Moderate)
Competitiveness In The Industry (High)
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Cases Of Diabetes And Obesity
Increasing Awareness Of Diagnosis And Treatment Options For Diabetes
Strong R&D Pipeline
Market Restraints
Product Failure
High Barriers For New Entrants
Market Opportunities
Extended Therapeutic Uses
Integration In Telehealth And Weight Management Program
Chapter 4 Regulatory Landscape
Regulatory Dynamics
U.S.
Europe
Japan
China
Chapter 5 Emerging Technologies And Pipeline Analysis
Emerging Trends/Technologies
Next-generation Multi-receptor Agonists
Innovative Drug Delivery Methods
Expanded Therapeutic Indications
Pipeline Analysis
Key Takeaways
Patent Analysis
Key Takeaways
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Global Glp-1 Analogues Market By Route Of Administration
Key Takeaways
Injectable
Oral
Geographic Breakdown
Global Glp-1 Analogue Market By Region
Key Takeaways
North America
Europe
Asia-pacific
South America
Middle East And Africa
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter 8 Sustainability In Glp-1 Analogues: Esg Perspective
Introduction To Esg
Sustainability In The Glp-1 Analogue Market
Esg Perspective
Environmental Impact
Social Impact
Governance Impact
Conclusion
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
Hansoh Pharmaceutical Group Co. Ltd.
Lilly Usa Llc.
Novo Nordisk A/S
Sanofi
Shanghai Benemae Pharmaceutical Corp.
Teva Pharmaceutical Industries Ltd.
Emerging Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us